libn.com
Stony Brook, NYU license possible lung disease cure to Nostrum
The medical schools at Stony Brook University and New York University have signed an exclusive license agreement with Nostrum Pharmaceuticals to develop a treatment for a potentially fatal lung dis…
Claude Solnik